Biofrontera AG annual capital expenditures (capex)
2021
2022
2023
2024
2025
Biofrontera AG Capital Expenditures (CapEx) Growth & History (B8FK)
Biofrontera AG's capital expenditures (capex) was €51,000 for fiscal 2025.
View full Biofrontera AG company overviewBiofrontera AG annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €51,000 | −€159,000 | −75.71% |
| 2024 | 2024-12-31 | €210,000 | −€702,000 | −76.97% |
| 2023 | 2023-12-31 | €912,000 | −€69,000 | −7.03% |
| 2022 | 2022-12-31 | €981,000 | €352,000 | +55.96% |
| 2021 | 2021-12-31 | €629,000 | — | — |
Biofrontera AG capital expenditures (capex) trends
Between the periods ended 2021-12-31 and 2025-12-31, Biofrontera AG's capital expenditures (capex) decreased from €629,000 to €51,000, a change of −€578,000.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company official filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Biofrontera AG source filings ↗